Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

329 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Involvement of novel human immunodeficiency virus type 1 reverse transcriptase mutations in the regulation of resistance to nucleoside inhibitors.
Svicher V, Sing T, Santoro MM, Forbici F, Rodríguez-Barrios F, Bertoli A, Beerenwinkel N, Bellocchi MC, Gago F, d'Arminio Monforte A, Antinori A, Lengauer T, Ceccherini-Silberstein F, Perno CF. Svicher V, et al. Among authors: santoro mm. J Virol. 2006 Jul;80(14):7186-98. doi: 10.1128/JVI.02084-05. J Virol. 2006. PMID: 16809324 Free PMC article.
Characterization and structural analysis of novel mutations in human immunodeficiency virus type 1 reverse transcriptase involved in the regulation of resistance to nonnucleoside inhibitors.
Ceccherini-Silberstein F, Svicher V, Sing T, Artese A, Santoro MM, Forbici F, Bertoli A, Alcaro S, Palamara G, d'Arminio Monforte A, Balzarini J, Antinori A, Lengauer T, Perno CF. Ceccherini-Silberstein F, et al. Among authors: santoro mm. J Virol. 2007 Oct;81(20):11507-19. doi: 10.1128/JVI.00303-07. Epub 2007 Aug 8. J Virol. 2007. PMID: 17686836 Free PMC article.
Viro-immunologic response to ritonavir-boosted or unboosted atazanavir in a large cohort of multiply treated patients: the CARe Study.
Santoro MM, Bertoli A, Lorenzini P, Lazzarin A, Esposito R, Carosi G, Di Perri G, Filice G, Moroni M, Rizzardini G, Caramello P, Maserati R, Narciso P, Cargnel A, Antinori A, Perno CF; CARe Study Group. Santoro MM, et al. AIDS Patient Care STDS. 2008 Jan;22(1):7-16. doi: 10.1089/apc.2007.0013. AIDS Patient Care STDS. 2008. PMID: 18095835 Clinical Trial.
Specific enfuvirtide-associated mutational pathways in HIV-1 Gp41 are significantly correlated with an increase in CD4(+) cell count, despite virological failure.
Svicher V, Aquaro S, D'Arrigo R, Artese A, Dimonte S, Alcaro S, Santoro MM, Di Perri G, Caputo SL, Bellagamba R, Zaccarelli M, Visco-Comandini U, Antinori A, Narciso P, Ceccherini-Silberstein F, Perno CF. Svicher V, et al. Among authors: santoro mm. J Infect Dis. 2008 May 15;197(10):1408-18. doi: 10.1086/587693. J Infect Dis. 2008. PMID: 18419549
Dynamics of NRTI resistance mutations during therapy interruption.
Trignetti M, Sing T, Svicher V, Santoro MM, Forbici F, D'arrigo R, Bellocchi MC, Santoro M, Marconi P, Zaccarelli M, Trotta MP, Bellagamba R, Narciso P, Antinori A, Lengauer T, Perno CF, Ceccherini-Silberstein F. Trignetti M, et al. Among authors: santoro m, santoro mm. AIDS Res Hum Retroviruses. 2009 Jan;25(1):57-64. doi: 10.1089/aid.2008.0159. AIDS Res Hum Retroviruses. 2009. PMID: 19182921
Is there any potential for first-line etravirine use? Analysis from a large data set of antiretroviral therapy-naive HIV-infected patients undergoing resistance test.
Zaccarelli M, Antinori A, Cozzi-Lepri A, Mussini C, Palamara G, Santoro MM, Spagnuolo V, Monforte Ad, Perno CF, Ceccherini-Silberstein F. Zaccarelli M, et al. Among authors: santoro mm. J Acquir Immune Defic Syndr. 2010 Jan;53(1):150-1. doi: 10.1097/QAI.0b013e3181c428b4. J Acquir Immune Defic Syndr. 2010. PMID: 20035165 No abstract available.
329 results